Because we detected S100A8/A9 upregulation in the serum and brains in mice with colitis (Figs. 3, 4), we hypothesized that inhibition of S100A9-signaling would reduce the neuroinflammatory signature in mice with colitis. This evidence concerns the gene S100A9 and colitis.